TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 81 filers reported holding TRINITY BIOTECH PLC in Q4 2015. The put-call ratio across all filers is 79.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,261,000 | +24.0% | 171,001 | +6.4% | 0.17% | +17.4% |
| Q2 2016 | $1,823,000 | +1.8% | 160,762 | +4.7% | 0.14% | -11.1% |
| Q1 2016 | $1,791,000 | +6.3% | 153,555 | +7.2% | 0.16% | +6.6% |
| Q4 2015 | $1,685,000 | -71.3% | 143,267 | -72.0% | 0.15% | -73.0% |
| Q3 2015 | $5,862,000 | -19.5% | 512,463 | +27.1% | 0.56% | -16.3% |
| Q2 2015 | $7,284,000 | -20.3% | 403,333 | -15.0% | 0.67% | -14.4% |
| Q1 2015 | $9,138,000 | +101.9% | 474,722 | +83.7% | 0.79% | +54.4% |
| Q4 2014 | $4,525,000 | +76.3% | 258,391 | +83.9% | 0.51% | +45.0% |
| Q3 2014 | $2,567,000 | +17.4% | 140,530 | +48.1% | 0.35% | +13.2% |
| Q2 2014 | $2,186,000 | +94.3% | 94,912 | +104.4% | 0.31% | +77.1% |
| Q1 2014 | $1,125,000 | -16.5% | 46,431 | -13.4% | 0.18% | -15.5% |
| Q4 2013 | $1,347,000 | +18.7% | 53,596 | +2.7% | 0.21% | +12.5% |
| Q3 2013 | $1,135,000 | +27.7% | 52,170 | -1.1% | 0.18% | +17.2% |
| Q2 2013 | $889,000 | – | 52,730 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |